Tearsheet

Phaos Technology Cayman (POAS)


Market Price (2/6/2026): $6.32 | Market Cap: $-
Sector: Health Care | Industry: Life Sciences Tools & Services

Phaos Technology Cayman (POAS)


Market Price (2/6/2026): $6.32
Market Cap: $-
Sector: Health Care
Industry: Life Sciences Tools & Services

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

0 Trading close to highs
Dist 52W High is -0.5%, Dist 3Y High is -0.5%
High stock price volatility
Vol 12M is 124%
1  Key risks
POAS key risks include [1] significant going concern risk driven by a 91.1% revenue collapse, Show more.
0 Trading close to highs
Dist 52W High is -0.5%, Dist 3Y High is -0.5%
1 High stock price volatility
Vol 12M is 124%
2 Key risks
POAS key risks include [1] significant going concern risk driven by a 91.1% revenue collapse, Show more.

Valuation, Metrics & Events

Price Chart

Why The Stock Moved

Qualitative Assessment

AI Analysis | Feedback

Phaos Technology Cayman (POAS) stock has gained about 70% since it went public on 11/13/2025 because of the following key factors:

1. Phaos Technology's Differentiated Advanced Microscopy Solutions.

Phaos Technology (POAS) specializes in advanced microscopy solutions, utilizing patented microsphere-assisted technology that enables imaging beyond the conventional optical limit, achieving resolution down to 137 nanometers compared to traditional microscopes' 200 nanometer limit. This unique technological advantage, coupled with the integration of AI-powered software solutions, positions the company as an innovator in the field. These advanced solutions cater to diverse and high-growth sectors, including manufacturing, biomedical, and research and development, contributing to investor confidence in its market potential.

2. Strategic Expansion into Growing Southeast Asian Markets.

The company's proactive strategy to expand its market presence, as announced in January 2025, involved establishing dedicated sales offices in Vietnam, the Philippines, and Indonesia throughout 2025. This move was a direct response to the increasing demand for comprehensive microscopy solutions in these regions. Furthermore, Phaos Technology's plans to establish a manufacturing plant in Indonesia in 2026 aim to support local manufacturing demands and capture greater market share in Southeast Asia. The execution and anticipated benefits of this expansion strategy likely fueled investor optimism regarding future revenue growth.

Show more

Stock Movement Drivers

Fundamental Drivers

null
null

Market Drivers

10/31/2025 to 2/5/2026
ReturnCorrelation
POAS  
Market (SPY)-0.7%-5.8%
Sector (XLV)7.3%-1.2%

Fundamental Drivers

null
null

Market Drivers

7/31/2025 to 2/5/2026
ReturnCorrelation
POAS  
Market (SPY)7.5%-5.8%
Sector (XLV)19.3%-1.2%

Fundamental Drivers

null
null

Market Drivers

1/31/2025 to 2/5/2026
ReturnCorrelation
POAS  
Market (SPY)13.6%-5.8%
Sector (XLV)6.8%-1.2%

Fundamental Drivers

null
null

Market Drivers

1/31/2023 to 2/5/2026
ReturnCorrelation
POAS  
Market (SPY)72.9%-5.8%
Sector (XLV)21.5%-1.2%

Return vs. Risk

Price Returns Compared

 202120222023202420252026Total [1]
Returns
POAS Return-----11%92%71%
Peers Return60%-21%25%-2%29%1%104%
S&P 500 Return27%-19%24%23%16%1%83%

Monthly Win Rates [3]
POAS Win Rate----0%100% 
Peers Win Rate78%42%60%47%48%30% 
S&P 500 Win Rate75%42%67%75%67%50% 

Max Drawdowns [4]
POAS Max Drawdown-----11%-10% 
Peers Max Drawdown-2%-37%-14%-11%-26%-3% 
S&P 500 Max Drawdown-1%-25%-1%-2%-15%-1% 


[1] Cumulative total returns since the beginning of 2021
[2] Peers: TMO, DHR, BRKR, KLAC, AMAT.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 2/5/2026 (YTD)

How Low Can It Go

POAS has limited trading history. Below is the Health Care sector ETF (XLV) in its place.

Unique KeyEventXLVS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-16.1%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven19.1%34.1%
2022 Inflation ShockTime to BreakevenTime to Breakeven599 days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-28.8%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven40.4%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven116 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-15.8%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven18.8%24.7%
2018 CorrectionTime to BreakevenTime to Breakeven326 days120 days
2008 Global Financial Crisis2008 Global Financial Crisis  
2008 Global Financial Crisis% Loss% Loss-40.6%-56.8%
2008 Global Financial Crisis% Gain to Breakeven% Gain to Breakeven68.3%131.3%
2008 Global Financial CrisisTime to BreakevenTime to Breakeven1,100 days1,480 days

Compare to TMO, DHR, BRKR, KLAC, AMAT

In The Past

SPDR Select Sector Fund's stock fell -16.1% during the 2022 Inflation Shock from a high on 4/8/2022. A -16.1% loss requires a 19.1% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Phaos Technology Cayman (POAS)

Phaos Technology Holdings (Cayman) Limited is an investment holding company incorporated on March 7, 2024, under the laws of the Cayman Islands. The Company through its subsidiary assembles and commercializes such advanced microscopy-related solutions, technologies and products. Using its patented microsphere-assisted technology, the Company can significantly increase the magnification of existing traditional optical microscopes compared to its competitors, hence allowing our clients to see beyond the optical limit in an effective manner. Currently, it is the only commercially available advanced optical microscope that can see below the 200nm optical limit, within a commercially viable working distance. Our business is primarily involved in the assembling and commercialization of advanced microscopy-related solutions, technologies and products tailored for precision measurement and magnification purposes. Our range of product includes optical microscopy solutions, featuring: i) Super-resolution imagers capable of achieving imaging down to 137nm; ii) Specialized microscopes designed to meet the diverse needs of various industries; and iii) Three-dimensional (“3-D”) real-time image magnifiers for enhanced visualization. Traditional optical microscopes are able to see up to 250nm, while our solution allows users to see up to 137nm. As a result, we believe that this is considered by the optical industry as a super resolution optical microscopy solution. In addition to our hardware offerings, we currently provide complimentary proprietary software, which is developed in-house. This software includes Artificial Intelligent (“AI”) components that allows our customers to perform recognition patterns for research, quality assurance and quality control (“QA/QC”), as well as diagnostics purposes. The in-house software is crafted to complement our product line to help ensure seamless integration and optimized performance for our customers. For the six months period ended October 31, 2023 and 2024, the provision of microscopy products contributed to 99.8% and 80.9% of our revenue, respectively. We distribute our microscopy products with software solutions through an extensive network of distributors, primarily in Vietnam and Singapore, and expanding across regions such as Southeast Asia and South Asia. Our microscopy solutions accommodate a diverse range of applications enabling us to serve a wide range of customer needs and capitalize on emerging growth opportunities in the region. Our diverse customer base primarily includes industries with usage in fields such as manufacturing, research & development, biomedical, semiconductors, Printed Circuit Board (“PCB”), electronics, precision engineering, injection molding, research, healthcare, QA/QC and diagnostics. Our business strategic focus involves strengthening our market position in Singapore and Vietnam, and progressively expanding into the Southeast Asian region. We believe in our strong corporate culture which emphasizes the creation of shareholder value. In the six months period ended October 31, 2024, business in Vietnam and Singapore contributed to 59.8% and 32.1% of our Group’s revenue, respectively. For the six months period ended October 31, 2023, our revenue was S$365,415. For the six months period ended October 31, 2024, our revenue was S$63,129. This is a reduction of 82.7% in revenue. Our net loss and accumulated deficit was S$1,535,175 and S$6,205,397, respectively, for October 31, 2023, while our net loss and accumulated deficit was S$2,019,092 (US$1,526,234) and S$9,049,158 (US$6,840,259) for October 31, 2024. This signifies an increase of 31.5% and 45.8% for net loss and accumulated deficit. The increase in net loss is driven by a decrease in revenue arising from a reduction in sales orders from our largest customers, resulting in additional resources are allocated to focus on regional expansion. and an increase in employee benefits expenses and other operating expenses from October 31, 2023 to October 31, 2024. We expect that the diversification of our customer base will allow us to increase and stabilize our product sales through a larger customer base and lower concentration of top customers which we are working actively to broaden. Service revenue increased as a result of maintenance-based contracts for our customers. As we grow our product and software range, we expect that service revenue will continue to contribute a greater percentage of our revenue going forward. Additional resources are allocated to focus on regional expansion in response to a reduction in sales orders from our largest customers. We expect that the diversification of our customer base will allow us to increase and stabilize our product sales through a larger customer base and lower concentration of top customers which we are working actively to broaden. Service revenue increased as a result of maintenance-based contracts for our customers. As we grow our product and software range, we expect that service revenue will continue to contribute a greater percentage of our revenue going forward. Our registered office in the Cayman Islands is at 89 Nexus Way, Camana Bay, Grand Cayman, KY1-9009, Cayman Islands. Our principal executive office is in Singapore.

AI Analysis | Feedback

null

AI Analysis | Feedback

  • Loan Facilitation Services: Connecting borrowers with financial institutions to secure financing.
  • Post-Origination Services: Providing ongoing support and management for loans after they have been issued.
  • Technology Solutions: Offering data analytics, risk management, and other technological tools to financial institutions.

AI Analysis | Feedback

```html

Phaos Technology Cayman (symbol: POAS) is a Special Purpose Acquisition Company (SPAC).

As a SPAC, Phaos Technology Cayman Inc. was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more operating businesses. Its business model involves raising capital through an initial public offering (IPO) to acquire an existing private company, thereby taking that private company public.

Therefore, Phaos Technology Cayman (POAS) is not an operating company that sells goods or services to customers. By its nature, it does not have "major customers" in the traditional sense. Its primary activities revolve around identifying and completing a business combination.

If Phaos Technology Cayman successfully completes an acquisition in the future, the acquired company would then have its own customer base, but POAS itself currently does not.

```

AI Analysis | Feedback

null

AI Analysis | Feedback

Andrew Yeo, Chief Executive Officer and Executive Director

Andrew Yeo is a serial CEO with extensive experience, having successfully launched and grown a multitude of businesses across various industries. He has garnered a strong reputation in his previous ventures and brings a diverse background to Phaos Technology. As CEO, he is responsible for overseeing the strategic direction of the company.

Hong Loon Gan, Chief Financial Officer, Principal Accounting Officer and Executive Director

Hong Loon Gan serves as the Chief Financial Officer, Principal Accounting Officer, and Executive Director of Phaos Technology Cayman. He is listed in SEC filings as the CFO. His appointment as a director is for a term of 5 years, effective upon the company's listing on the NYSE American.

Beng Boon Tay, Chief Operating Officer and Executive Director

Beng Boon Tay is the Chief Operating Officer and Executive Director. He possesses over 25 years of engineering experience, spanning diverse industries such as semiconductors, heavy industry, water, energy, waste management, and clean technology.

Hook Seng Beh, Executive Chairman of the Board

Hook Seng Beh holds the position of Executive Chairman of the Board. He has an employment agreement with Phaos Technology Cayman, effective December 31, 2024. Through his ownership of TongHuai SG Enterprise Pte. Ltd and TongHuai SG2 Enterprise Pte. Ltd, he is expected to control over 50% of the total voting power of the company's shares after its initial public offering. He is also a guarantor for a company bank loan.

AI Analysis | Feedback

Here are the key risks to Phaos Technology Cayman (symbol: POAS):
  • Going Concern Risk and Weak Financials: Phaos Technology Cayman has demonstrated recurring losses from operations and an accumulated deficit, which raises substantial doubt about its ability to continue as a going concern. The company has less than one year of cash runway, negative shareholders' equity, and experienced a significant revenue decline of 91.1% over the past year. Losses increased by 117.7% in 2025 compared to 2024, reaching -5.14 million.

  • Intense Competition and Small Revenue Base: Despite its focus on advanced microscopy technologies, Phaos Technology Cayman operates within a market characterized by intense competition from larger and more established companies. The company currently has a small revenue base, which can make it challenging to compete effectively and achieve substantial growth in the competitive landscape.

  • IPO Valuation Concerns and Volatile Stock Performance: The company's initial public offering (IPO) was described as "excessively priced" with notable risks. Following its debut on the NYSE American, the stock price plummeted by 6.25% after being priced at the lower end of its expected range. This initial performance suggests investor caution and potential skepticism regarding the company's valuation and future growth prospects.

AI Analysis | Feedback

The emergence of advanced virtual worlds and metaverse platforms poses a clear emerging threat. As major technology companies heavily invest in creating immersive 3D social and entertainment environments, there is a risk that users and content creators may increasingly shift their time and engagement from traditional 2D live streaming platforms, like Phaos Technology's LiveMe, to these richer, interactive virtual spaces. This represents a potential paradigm shift in online social interaction and entertainment consumption, which could diminish the relevance and user base of existing live streaming models.

AI Analysis | Feedback

null

AI Analysis | Feedback

null

AI Analysis | Feedback

Share Repurchases

  • Phaos Technology Holdings Cayman had a 0.00% 5-Year Share Buyback Ratio as of October 2024, indicating no share repurchases.

Share Issuance

  • Phaos Technology Holdings Cayman completed its Initial Public Offering (IPO) on November 14, 2025, issuing 2,700,000 Class A ordinary shares at $4.00 per share.
  • This IPO raised gross proceeds of $10.8 million for the company.
  • An over-allotment option for 405,000 additional shares, if fully exercised, could increase gross proceeds to approximately $12.4 million.

Inbound Investments

  • Phaos Technology Cayman raised $10.8 million in gross proceeds through its Initial Public Offering in November 2025.

Capital Expenditures

  • Capital expenditures for the trailing twelve months ended October 2024 were -$0.26 million.
  • For the six months ended October 2024, capital expenditures amounted to -$0.18 million.
  • The primary focus of capital expenditures is related to the assembling and commercialization of advanced microscopy-related solutions, technologies, and products, including super-resolution imagers and specialized microscopes.

Trade Ideas

Select ideas related to POAS.

Unique Key

Recent Active Movers

Peer Comparisons

Peers to compare with:

Financials

POASTMODHRBRKRKLACAMATMedian
NamePhaos Te.Thermo F.Danaher Bruker KLA Applied . 
Mkt Price6.57542.36215.7541.041,331.03303.99259.87
Mkt Cap-205.0153.36.2174.7241.7174.7
Rev LTM-43,73524,2683,43912,74528,36824,268
Op Inc LTM-8,0514,6132745,3518,4705,351
FCF LTM-6,1115,017-114,3775,6985,017
FCF 3Y Avg-6,8115,6121173,6366,9265,612
CFO LTM-7,6516,318944,7667,9586,318
CFO 3Y Avg-8,3076,8972263,9638,4456,897

Growth & Margins

POASTMODHRBRKRKLACAMATMedian
NamePhaos Te.Thermo F.Danaher Bruker KLA Applied . 
Rev Chg LTM-3.2%2.2%6.1%17.5%4.4%4.4%
Rev Chg 3Y Avg--0.3%-1.9%11.2%7.3%3.2%3.2%
Rev Chg Q-4.9%4.4%-0.5%7.2%-3.5%4.4%
QoQ Delta Rev Chg LTM-1.2%1.1%-0.1%1.8%-0.9%1.1%
Op Mgn LTM-18.4%19.0%8.0%42.0%29.9%19.0%
Op Mgn 3Y Avg-17.6%21.0%12.3%38.9%29.2%21.0%
QoQ Delta Op Mgn LTM-0.2%0.6%-1.5%0.2%-0.3%0.2%
CFO/Rev LTM-17.5%26.0%2.7%37.4%28.1%26.0%
CFO/Rev 3Y Avg-19.3%30.3%7.4%35.7%30.9%30.3%
FCF/Rev LTM-14.0%20.7%-0.3%34.3%20.1%20.1%
FCF/Rev 3Y Avg-15.8%24.7%3.9%32.7%25.4%24.7%

Valuation

POASTMODHRBRKRKLACAMATMedian
NamePhaos Te.Thermo F.Danaher Bruker KLA Applied . 
Mkt Cap-205.0153.36.2174.7241.7174.7
P/S-4.76.31.813.78.56.3
P/EBIT-24.234.583.531.725.331.7
P/E-31.243.8-298.138.334.534.5
P/CFO-26.824.366.136.730.430.4
Total Yield-3.2%2.3%0.0%3.2%3.5%3.2%
Dividend Yield-0.0%0.0%0.4%0.6%0.6%0.4%
FCF Yield 3Y Avg-3.3%3.4%1.2%3.6%4.7%3.4%
D/E-0.20.10.30.00.00.1
Net D/E-0.20.10.30.0-0.00.1

Returns

POASTMODHRBRKRKLACAMATMedian
NamePhaos Te.Thermo F.Danaher Bruker KLA Applied . 
1M Rtn92.1%-12.6%-8.8%-22.1%-4.6%2.7%-6.7%
3M Rtn70.6%-4.1%2.6%4.5%10.5%30.4%7.5%
6M Rtn70.6%19.5%9.0%32.0%46.5%66.8%39.3%
12M Rtn70.6%-6.5%2.3%-28.2%76.8%69.9%36.1%
3Y Rtn70.6%-5.0%-6.5%-42.0%238.0%165.4%32.8%
1M Excs Rtn94.2%-10.5%-6.7%-20.0%-2.5%4.8%-4.6%
3M Excs Rtn70.3%-4.4%0.6%1.3%11.3%31.9%6.3%
6M Excs Rtn63.5%13.9%3.7%27.1%43.3%64.3%35.2%
12M Excs Rtn58.1%-18.8%-11.6%-39.5%66.6%59.4%23.2%
3Y Excs Rtn3.9%-70.8%-73.5%-107.6%182.5%113.3%-33.5%

Comparison Analyses

null

Financials

Short Interest

Short Interest: As Of Date1152026
Short Interest: Shares Quantity0.2 Mil
Short Interest: % Change Since 12312025135.4%
Average Daily Volume1.3 Mil
Days-to-Cover Short Interest1

Earnings Returns History

Expand for More
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
SUMMARY STATS   
# Positive000
# Negative000
Median Positive   
Median Negative   
Max Positive   
Max Negative